Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
20–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with mild to moderate hypertension with office diastolic BP (DBP) 90-109 mmHg and/or systolic BP (SBP) 140-179 mmHg before entering each treatment
You may not be if
females: who are pregnant or breast feeding
office DBP ≧ 110 mmHg or office SBP ≧ 180 mmHg
history of significant cardiovascular diseases which include: acute myocardial infarction within six months or any ischemic heart disease requiring medication, or cerebrovascular disease
history of significant renal diseases including: serum creatinine \> 3.0 mg/dl, or creatinine clearance \< 30 ml/min.
severe biliary cirrhosis and cholestasis
refractory hypokalemia, hypercalcemia
history of autoimmune disease, collagen vascular disease, multiple drug allergies, bronchospastic disease or other malignancies requiring current medication
hepatic disease as indicated by any of the following : Serum Glutamic Oxaloacetic Transaminase (SGOT) or Serum Glutamic Pyruvate Transaminase (SGPT) \>3 x upper limit of normal, or serum bilirubin \> 2 x upper limit of normal
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Clareo Health | Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
